Suppr超能文献

尽管通过抗氧化剂治疗提高了成肌细胞的存活率,但其心脏再生潜力仍然有限。

The cardiac regenerative potential of myoblasts remains limited despite improving their survival via antioxidant treatment.

作者信息

Beckman Sarah A, Sekiya Naosumi, Chen William C W, Mlakar Logan, Tobita Kimimassa, Huard Johnny

机构信息

Department of Pathology, University of Pittsburgh, Pittsburgh, PA, U.S.A.

Stem Cell Research Center, University of Pittsburgh, Pittsburgh, PA, U.S.A.

出版信息

CellR4 Repair Replace Regen Reprogram. 2014;2(2). Epub 2014 Mar 31.

Abstract

INTRODUCTION

Since myoblasts have been limited by poor cell survival after cellular myoplasty, the major goal of the current study was to determine whether improving myoblast survival with an antioxidant could improve cardiac function after the transplantation of the myoblasts into an acute myocardial infarction.

BACKGROUND

We previously demonstrated that early myogenic progenitors such as muscle-derived stem cells (MDSCs) exhibited superior cell survival and improved cardiac repair after transplantation into infarcted hearts compared to myoblasts, which we partially attributed to MDSC's higher antioxidant levels.

AIM

To determine if antioxidant treatment could increase myoblast survival, subsequently improving cardiac function after myoblast transplantation into infarcted hearts.

MATERIALS AND METHODS

Myoblasts were pre-treated with the antioxidant N-acetylcysteine (NAC) or the glutathione depleter, diethyl maleate (DEM), and injected into infarcted murine hearts. Regenerative potential was monitored by cell survival and cardiac function.

RESULTS

At early time points, hearts injected with NAC-treated myoblasts exhibited increased donor cell survival, greater cell proliferation, and decreased cellular apoptosis, compared to untreated myoblasts. NAC-treated myoblasts significantly improved cardiac contractility, reduced fibrosis, and increased vascular density compared to DEM-treated myoblasts, but compared to untreated myoblasts, no difference was noted.

DISCUSSION

While early survival of myoblasts transplanted into infarcted hearts was augmented by NAC pre-treatment, cardiac function remained unchanged compared to non-treated myoblasts.

CONCLUSION

Despite improving cell survival with NAC treated myoblast transplantation in a MI heart, cardiac function remained similar to untreated myoblasts. These results suggest that the reduced cardiac regenerative potential of myoblasts, when compared to MDSCs, is not only attributable to cell survival but is probably also related to the secretion of paracrine factors by the MDSCs.

摘要

引言

由于成肌细胞在细胞性肌成形术后受细胞存活率低的限制,本研究的主要目的是确定用抗氧化剂提高成肌细胞存活率是否能在将成肌细胞移植到急性心肌梗死后改善心脏功能。

背景

我们之前证明,与成肌细胞相比,早期肌源性祖细胞如肌肉衍生干细胞(MDSCs)在移植到梗死心脏后表现出更高的细胞存活率和更好的心脏修复效果,我们将其部分归因于MDSC更高的抗氧化剂水平。

目的

确定抗氧化剂治疗是否能增加成肌细胞存活率,进而在将成肌细胞移植到梗死心脏后改善心脏功能。

材料与方法

成肌细胞用抗氧化剂N-乙酰半胱氨酸(NAC)或谷胱甘肽耗竭剂马来酸二乙酯(DEM)预处理,然后注入梗死的小鼠心脏。通过细胞存活率和心脏功能监测再生潜能。

结果

在早期时间点,与未处理的成肌细胞相比,注射用NAC处理的成肌细胞的心脏表现出供体细胞存活率增加、细胞增殖更多和细胞凋亡减少。与用DEM处理的成肌细胞相比,用NAC处理的成肌细胞显著改善了心脏收缩力、减少了纤维化并增加了血管密度,但与未处理的成肌细胞相比,未观察到差异。

讨论

虽然用NAC预处理可提高移植到梗死心脏的成肌细胞的早期存活率,但与未处理的成肌细胞相比,心脏功能没有变化。

结论

尽管在心肌梗死心脏中用NAC处理的成肌细胞移植可提高细胞存活率,但心脏功能与未处理的成肌细胞相似。这些结果表明,与MDSCs相比,成肌细胞心脏再生潜能降低不仅归因于细胞存活率,还可能与MDSCs旁分泌因子的分泌有关。

相似文献

2
Cellular antioxidant levels influence muscle stem cell therapy.细胞抗氧化水平影响肌肉干细胞治疗。
Mol Ther. 2010 Oct;18(10):1865-73. doi: 10.1038/mt.2010.160. Epub 2010 Jul 27.
10
Effect of sphingosine-1-phosphate and myoblast transplantation on rat acute myocardial infarction.
Genet Mol Res. 2015 Oct 30;14(4):13843-51. doi: 10.4238/2015.October.29.4.

本文引用的文献

2
Empowering adult stem cells for myocardial regeneration.赋予成人干细胞心肌再生的能力。
Circ Res. 2011 Dec 9;109(12):1415-28. doi: 10.1161/CIRCRESAHA.111.243071.
3
Cellular antioxidant levels influence muscle stem cell therapy.细胞抗氧化水平影响肌肉干细胞治疗。
Mol Ther. 2010 Oct;18(10):1865-73. doi: 10.1038/mt.2010.160. Epub 2010 Jul 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验